About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Global In Vitro Toxicology Assays Market Size, Top Share to 2031
In Vitro Toxicology Assays Market

In Vitro Toxicology Assays Market Size, Share & Trends Analysis Report By Test Type (Cannabis Testing, Nicotine Testing), By Technology (3D Cell Culture Technology, Mass Spectrometry, Flow Cytometry, Others), By Application (Genetic Toxicity Testing, Carcinogenicity Testing, Cytotoxicity Testing, Mutagenicity Testing, Others), By Method (Cellular Assay, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI55321DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global In Vitro Toxicology Assays Market Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Cannabis Testing
        1. By Value
      3. Nicotine Testing
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. 3D Cell Culture Technology
        1. By Value
      3. Mass Spectrometry
        1. By Value
      4. Flow Cytometry
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Genetic Toxicity Testing
        1. By Value
      3. Carcinogenicity Testing
        1. By Value
      4. Cytotoxicity Testing
        1. By Value
      5. Mutagenicity Testing
        1. By Value
      6. Others
        1. By Value
    5. By Method
      1. Introduction
        1. Method By Value
      2. Cellular Assay
        1. By Value
        2. Live Cells
          1. Live Cells By Value
          2. High Throughput
            1. High Throughput By Value
          3. High Content Screening
            1. High Content Screening By Value
          4. Molecular Imaging
            1. Molecular Imaging By Value
          5. Others
            1. Others By Value
        3. Fixed Cells
          1. Fixed Cells By Value
      3. Others
        1. By Value
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Cannabis Testing
        1. By Value
      3. Nicotine Testing
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. 3D Cell Culture Technology
        1. By Value
      3. Mass Spectrometry
        1. By Value
      4. Flow Cytometry
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Genetic Toxicity Testing
        1. By Value
      3. Carcinogenicity Testing
        1. By Value
      4. Cytotoxicity Testing
        1. By Value
      5. Mutagenicity Testing
        1. By Value
      6. Others
        1. By Value
    5. By Method
      1. Introduction
        1. Method By Value
      2. Cellular Assay
        1. By Value
        2. Live Cells
          1. Live Cells By Value
          2. High Throughput
            1. High Throughput By Value
          3. High Content Screening
            1. High Content Screening By Value
          4. Molecular Imaging
            1. Molecular Imaging By Value
          5. Others
            1. Others By Value
        3. Fixed Cells
          1. Fixed Cells By Value
      3. Others
        1. By Value
    6. U.S.
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Cannabis Testing
          1. By Value
        3. Nicotine Testing
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. 3D Cell Culture Technology
          1. By Value
        3. Mass Spectrometry
          1. By Value
        4. Flow Cytometry
          1. By Value
        5. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Genetic Toxicity Testing
          1. By Value
        3. Carcinogenicity Testing
          1. By Value
        4. Cytotoxicity Testing
          1. By Value
        5. Mutagenicity Testing
          1. By Value
        6. Others
          1. By Value
      4. By Method
        1. Introduction
          1. Method By Value
        2. Cellular Assay
          1. By Value
          2. Live Cells
            1. Live Cells By Value
            2. High Throughput
              1. High Throughput By Value
            3. High Content Screening
              1. High Content Screening By Value
            4. Molecular Imaging
              1. Molecular Imaging By Value
            5. Others
              1. Others By Value
          3. Fixed Cells
            1. Fixed Cells By Value
        3. Others
          1. By Value
    7. Canada
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Cannabis Testing
        1. By Value
      3. Nicotine Testing
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. 3D Cell Culture Technology
        1. By Value
      3. Mass Spectrometry
        1. By Value
      4. Flow Cytometry
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Genetic Toxicity Testing
        1. By Value
      3. Carcinogenicity Testing
        1. By Value
      4. Cytotoxicity Testing
        1. By Value
      5. Mutagenicity Testing
        1. By Value
      6. Others
        1. By Value
    5. By Method
      1. Introduction
        1. Method By Value
      2. Cellular Assay
        1. By Value
        2. Live Cells
          1. Live Cells By Value
          2. High Throughput
            1. High Throughput By Value
          3. High Content Screening
            1. High Content Screening By Value
          4. Molecular Imaging
            1. Molecular Imaging By Value
          5. Others
            1. Others By Value
        3. Fixed Cells
          1. Fixed Cells By Value
      3. Others
        1. By Value
    6. U.K.
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Cannabis Testing
          1. By Value
        3. Nicotine Testing
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. 3D Cell Culture Technology
          1. By Value
        3. Mass Spectrometry
          1. By Value
        4. Flow Cytometry
          1. By Value
        5. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Genetic Toxicity Testing
          1. By Value
        3. Carcinogenicity Testing
          1. By Value
        4. Cytotoxicity Testing
          1. By Value
        5. Mutagenicity Testing
          1. By Value
        6. Others
          1. By Value
      4. By Method
        1. Introduction
          1. Method By Value
        2. Cellular Assay
          1. By Value
          2. Live Cells
            1. Live Cells By Value
            2. High Throughput
              1. High Throughput By Value
            3. High Content Screening
              1. High Content Screening By Value
            4. Molecular Imaging
              1. Molecular Imaging By Value
            5. Others
              1. Others By Value
          3. Fixed Cells
            1. Fixed Cells By Value
        3. Others
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Cannabis Testing
        1. By Value
      3. Nicotine Testing
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. 3D Cell Culture Technology
        1. By Value
      3. Mass Spectrometry
        1. By Value
      4. Flow Cytometry
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Genetic Toxicity Testing
        1. By Value
      3. Carcinogenicity Testing
        1. By Value
      4. Cytotoxicity Testing
        1. By Value
      5. Mutagenicity Testing
        1. By Value
      6. Others
        1. By Value
    5. By Method
      1. Introduction
        1. Method By Value
      2. Cellular Assay
        1. By Value
        2. Live Cells
          1. Live Cells By Value
          2. High Throughput
            1. High Throughput By Value
          3. High Content Screening
            1. High Content Screening By Value
          4. Molecular Imaging
            1. Molecular Imaging By Value
          5. Others
            1. Others By Value
        3. Fixed Cells
          1. Fixed Cells By Value
      3. Others
        1. By Value
    6. China
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Cannabis Testing
          1. By Value
        3. Nicotine Testing
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. 3D Cell Culture Technology
          1. By Value
        3. Mass Spectrometry
          1. By Value
        4. Flow Cytometry
          1. By Value
        5. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Genetic Toxicity Testing
          1. By Value
        3. Carcinogenicity Testing
          1. By Value
        4. Cytotoxicity Testing
          1. By Value
        5. Mutagenicity Testing
          1. By Value
        6. Others
          1. By Value
      4. By Method
        1. Introduction
          1. Method By Value
        2. Cellular Assay
          1. By Value
          2. Live Cells
            1. Live Cells By Value
            2. High Throughput
              1. High Throughput By Value
            3. High Content Screening
              1. High Content Screening By Value
            4. Molecular Imaging
              1. Molecular Imaging By Value
            5. Others
              1. Others By Value
          3. Fixed Cells
            1. Fixed Cells By Value
        3. Others
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Singapore
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Cannabis Testing
        1. By Value
      3. Nicotine Testing
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. 3D Cell Culture Technology
        1. By Value
      3. Mass Spectrometry
        1. By Value
      4. Flow Cytometry
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Genetic Toxicity Testing
        1. By Value
      3. Carcinogenicity Testing
        1. By Value
      4. Cytotoxicity Testing
        1. By Value
      5. Mutagenicity Testing
        1. By Value
      6. Others
        1. By Value
    5. By Method
      1. Introduction
        1. Method By Value
      2. Cellular Assay
        1. By Value
        2. Live Cells
          1. Live Cells By Value
          2. High Throughput
            1. High Throughput By Value
          3. High Content Screening
            1. High Content Screening By Value
          4. Molecular Imaging
            1. Molecular Imaging By Value
          5. Others
            1. Others By Value
        3. Fixed Cells
          1. Fixed Cells By Value
      3. Others
        1. By Value
    6. UAE
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Cannabis Testing
          1. By Value
        3. Nicotine Testing
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. 3D Cell Culture Technology
          1. By Value
        3. Mass Spectrometry
          1. By Value
        4. Flow Cytometry
          1. By Value
        5. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Genetic Toxicity Testing
          1. By Value
        3. Carcinogenicity Testing
          1. By Value
        4. Cytotoxicity Testing
          1. By Value
        5. Mutagenicity Testing
          1. By Value
        6. Others
          1. By Value
      4. By Method
        1. Introduction
          1. Method By Value
        2. Cellular Assay
          1. By Value
          2. Live Cells
            1. Live Cells By Value
            2. High Throughput
              1. High Throughput By Value
            3. High Content Screening
              1. High Content Screening By Value
            4. Molecular Imaging
              1. Molecular Imaging By Value
            5. Others
              1. Others By Value
          3. Fixed Cells
            1. Fixed Cells By Value
        3. Others
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Cannabis Testing
        1. By Value
      3. Nicotine Testing
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. 3D Cell Culture Technology
        1. By Value
      3. Mass Spectrometry
        1. By Value
      4. Flow Cytometry
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Genetic Toxicity Testing
        1. By Value
      3. Carcinogenicity Testing
        1. By Value
      4. Cytotoxicity Testing
        1. By Value
      5. Mutagenicity Testing
        1. By Value
      6. Others
        1. By Value
    5. By Method
      1. Introduction
        1. Method By Value
      2. Cellular Assay
        1. By Value
        2. Live Cells
          1. Live Cells By Value
          2. High Throughput
            1. High Throughput By Value
          3. High Content Screening
            1. High Content Screening By Value
          4. Molecular Imaging
            1. Molecular Imaging By Value
          5. Others
            1. Others By Value
        3. Fixed Cells
          1. Fixed Cells By Value
      3. Others
        1. By Value
    6. Brazil
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Cannabis Testing
          1. By Value
        3. Nicotine Testing
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. 3D Cell Culture Technology
          1. By Value
        3. Mass Spectrometry
          1. By Value
        4. Flow Cytometry
          1. By Value
        5. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Genetic Toxicity Testing
          1. By Value
        3. Carcinogenicity Testing
          1. By Value
        4. Cytotoxicity Testing
          1. By Value
        5. Mutagenicity Testing
          1. By Value
        6. Others
          1. By Value
      4. By Method
        1. Introduction
          1. Method By Value
        2. Cellular Assay
          1. By Value
          2. Live Cells
            1. Live Cells By Value
            2. High Throughput
              1. High Throughput By Value
            3. High Content Screening
              1. High Content Screening By Value
            4. Molecular Imaging
              1. Molecular Imaging By Value
            5. Others
              1. Others By Value
          3. Fixed Cells
            1. Fixed Cells By Value
        3. Others
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. In Vitro Toxicology Assays Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Stemina Biomarker Discovery
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Broughton Nicotine Services
    3. Labstat International
    4. IONTOX
    5. Toxikon
    6. Integrated Laboratory Systems
    7. Enthalpy Analytical
    8. PBR LaboratoriesInc
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Immuno-Oncology Assays Market Size The global immuno-oncology assays market size was valued at USD 4.11 billion in 2022 and is projected to reach USD 10.02 billion by 2031, growing at a CAGR of 10.4% during the forecast period (2023–2031). Im
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.